ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors With Losses of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
[ad_1] NEW YORK, Feb. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD, ADGI) between November 29, 2021 and December 14, 2021, both dates inclusive (the “Class Period”) of the important April 3, 2023 lead plaintiff deadline. SO WHAT: If you purchased Invivyd securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Invivyd class action, go to https://rosenlegal.com/submit-form/?case_id=11658 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 3, 2023. A lead plaintiff is a representative party acting on behalf of other class